Please assess the completion status of the following clinical trial:

Trial Title: Nitrates and IL-8 in Barrett's Esophagus

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~- Patients undergoing a clinicallly-indicated Esophagogastroduoedoscopy (EGD).~Exclusion Criteria:~* Comorbid inflammatory medical condition.~* Use of antiinflammatory (aspirin and NSAIDs) or immunosuppressants over the past 1 week.~* Use of nitrate containing medication in the past 1 week.~* Consumption of nitrate rich foods in preceding 24 hours.~* Known allergy to meat or nitrates

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Group 1-NSE (Type: None): Patients found to have grossly normal squamous epithelium during endoscopy
- Group 2-EEG (Type: None): Patients found to have grossly apparent erosive esophagitis \>1cm with Los Angeles Classification A-D
- Group 3-NDBE Short (Type: None): Patients with non-dysplastic Barrett's Esophagus (NDBE) \> 1cm (Short Segment)
- Group 4-NDBE Long (Type: None): Patients with non-dysplastic Barrett's Esophagus (NDBE) \> 1cm (Long Segment)
- Group 5 (Type: None): Barrett's Esophagus (BE) with high-grade dysplasia (HGD) or esophageal adenocarcinoma (EAC)
- Group 6-Esophagectomy (Type: None): Patients undergoing resection of esophageal cancer
- Group -7 Pilot and Feasibility (Type: None): Patients undergoing EGD with NSE, NDBE, BE-HGD, or EAC for feasibility of analytical techniques

Based on this trial design, predict the completion outcome and termination type (if applicable).